J&J wins FDA nod for Tecnis PureSee intraocular lens (JNJ:NYSE)

Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in cataract surgery. The company identified Tecnis PureSee as ...